"Our work is driven by a sense of urgency to find new treatments that will create a better future for patients and their families. Through the R&D Postdoctoral Challenge, we’re looking for novel ideas to advance pioneering research that may ultimately help more people reclaim their lives."
Dr Sharon Barr, Senior Vice President, Head of Research and Product Development at Alexion, AstraZeneca’s Rare Disease group
We have
183
projects in our pipeline
